CSF2 and neoplasm: GVAX is a granulocyte–macrophage colony-stimulating factor (GM-CSF) tumor cell vaccine which expresses multiple antigens and induces anti-tumor immune responses by cross-priming mechanisms to recruit antigen-presenting cells [81].